FDA Drug Recalls

Recalls / Class I

Class ID-0180-2026

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

POTASSIUM CHLORIDE Inj., 20 mEq total in 50 mL Flexible Container, Highly concentrated 400 mEq/L, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC# 0990-7077-14

Brand name
Potassium Chloride
Generic name
Potassium Chloride
Active ingredient
Potassium Chloride
Route
Intravenous
NDCs
0990-7074, 0990-7075, 0990-7077
FDA application
NDA020161
Affected lot / code info
Lot # 1030613, Exp Date: 09/30/2026

Why it was recalled

Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq

Recalling firm

Firm
Otsuka ICU Medical LLC
Manufacturer
ICU Medical Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
3900 Howard Ln, Austin, Texas 78728-6515

Distribution

Quantity
21,696 50mL flexible containers
Distribution pattern
US Nationwide.

Timeline

Recall initiated
2025-10-29
FDA classified
2025-11-24
Posted by FDA
2025-11-26
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0180-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.